Pharmacokinetic Evaluation of Eltrombopag in ITP Pediatric Patients

Pharmacokinetic Evaluation of Eltrombopag in ITP Pediatric Patients

Background: Eltrombopag (EPAG) is an oral thrombopoietin receptor agonist, approved for refractory primary immune thrombocytopenia (ITP) in pediatric patients. In two pediatric RCTs, EPAG led to an improvement of platelet counts and a reduction in bleeding severity. However, a significant number of...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Dionisi (Author), Sara Cairoli (Author), Raffaele Simeoli (Author), Francesca De Gennaro (Author), Valeria Paganelli (Author), Roberto Carta (Author), Francesca Rossi (Author), Carlo Dionisi-Vici (Author), Giuseppe Palumbo (Author), Bianca Maria Goffredo (Author)
Format: Book
Published: Frontiers Media S.A., 2021-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items